Abstract
AbstractThe in vitro anti-amylase activity of three different starch blockers, anti-amylasetablets derived from legume protein concentrate, was compared with that ofacarbose, a bacterial α -glucoside hydrolase inhibitor also containing anti-amylaseactivity. The potency of each of the starch blocker tablets was approximatelyequal, one tablet containing the same anti-amylase activity as 0.24 mg of acarbose.There was no significant reduction of the blood glucose response when 1, 2, 3, 4 or 10 starch-blocker tablets were given to 4 to 7 normal volunteers 5 min beforea test meal containing 50 g carbohydrate as white bread.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
